Omeros (OMER) EBITDA Margin (2010 - 2026)
Omeros (OMER) reported EBITDA Margin of 176.09% for Q1 2026, up 52.48% sequentially from 370.6% in Q2 2022.
Omeros (OMER) EBITDA Margin (2010 - 2026) Analysis & Trends
Omeros (OMER) has 14 years of EBITDA Margin data on file, last reported at 176.09% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin changed N/A year-over-year to 176.09%; the trailing twelve-month figure through Mar 2026 stood at 389.94% (down 64935.0% YoY), and the FY2020 full-year result was 212.59%, down 8197.0% from the prior year.
- EBITDA Margin rose to 176.09% in Q1 2026, from 370.6% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 176.09% in Q1 2026 to a low of 500.94% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 30.35% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | -176.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176.09% |
| Jun 30, 2022 | -370.60% |
| Mar 31, 2022 | -500.94% |
| Dec 31, 2021 | 53.69% |
| Sep 30, 2021 | -132.74% |
| Jun 30, 2021 | -158.24% |
| Mar 31, 2021 | -215.04% |
| Dec 31, 2020 | -318.06% |
| Sep 30, 2020 | -97.37% |
| Jun 30, 2020 | -204.58% |
| Mar 31, 2020 | -100.59% |
| Dec 31, 2019 | -70.93% |
| Sep 30, 2019 | -37.18% |
| Jun 30, 2019 | -34.90% |
| Mar 31, 2019 | -88.34% |
| Dec 31, 2018 | -83.91% |
| Sep 30, 2018 | -769.14% |
| Jun 30, 2018 | -1,849.97% |
| Mar 31, 2018 | -1,743.64% |
| Dec 31, 2017 | -102.62% |